The “No-Error Era” for AI Chip Stocks: Marvell Meets Expectations Yet Plunges 11%

TradingKey - Custom chip giant Marvell Technology (MRVL) reported its latest quarterly results:

• Q2 revenue hit a record $2.01 billion, up 58% year-over-year
• Adjusted EPS of $0.67, in line with market expectations

Despite delivering solid results, the stock plummeted 11.28% in after-hours trading after its Q3 revenue guidance came in slightly below expectations. The company forecasted a midpoint of $2.06 billion, compared to the consensus estimate of $2.11 billion — a narrow miss that was enough to trigger a sharp sell-off. Year-to-date, Marvell shares are now down over 30%.

[Source: Google Finance]

The market reaction underscores a new reality: in the high-stakes world of AI chip stocks, simply meeting expectations is no longer enough.

CEO Matt Murphy emphasized that demand for Marvell’s AI-optimized custom chips and electro-optical products is at “historically high levels,” with data center business now accounting for three-quarters of total revenue. He explained that growth in custom silicon is inherently “non-linear” — with Q3 expected to be flat, but a “significant acceleration” anticipated in Q4.

The company has also completed the spin-off of its automotive Ethernet business to sharpen its focus on AI and data center opportunities, and will now report non-data-center segments as a combined category.

The severity of the market’s reaction highlights how little room for error remains in a high-valuation environment.

• Zacks Investment Research noted that elevated valuations earlier this year have left AI chip stocks extremely sensitive to any sign of deceleration.
• While Morgan Stanley argues that Marvell’s high-margin optical solutions are undervalued and that its collaboration with Amazon on “XPU attach” projects offers long-term upside, investors are demanding immediate, above-consensus results.

Marvell’s situation reflects a broader shift in the AI investment landscape: the market is moving from “story-driven” optimism to “execution-driven” scrutiny. In this new phase, even a temporary pause in growth momentum can trigger a sharp re-rating of expectations and valuations.